SCHEMBL257672

SCHEMBL257672

COCCc1cc(C(=O)c2ccccc2F)ccc1C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KMT2A Q03164 3/20 0.46
POLB P06746 2/20 0.43
LMNA P02545 1/20 0.43
PYGL P06737 1/20 0.42
TSHR P16473 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPT P10636 1/20 0.42
ABCC9 O60706 1/20 0.41
ABCC8 Q09428 1/20 0.41
KCNJ11 Q14654 1/20 0.41
KCNJ8 Q15842 1/20 0.41
MAPK14 Q16539 3/20 0.40
CXCR2 P25025 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL257668 0.89 CDC25A (0.46) ALDH1A1L3MBTL1KMT2APOLBLMNA
SCHEMBL15197152 0.85 KMT2A (0.45) ALDH1A1L3MBTL1KMT2APOLBTSHR
SCHEMBL15100959 0.83 ALDH1A1 (0.46) ALDH1A1L3MBTL1KMT2APOLBLMNA
SCHEMBL10047545 0.80 ALDH1A1 (0.55) ALDH1A1L3MBTL1KMT2APOLBLMNA
SCHEMBL257352 0.79 LMNA (0.54) ALDH1A1L3MBTL1KMT2APOLBLMNA
SCHEMBL10047113 0.78 KMT2A (0.51) ALDH1A1L3MBTL1KMT2APOLBPYGL
SCHEMBL257243 0.77 ALDH1A1 (0.48) ALDH1A1L3MBTL1KMT2APOLBLMNA
SCHEMBL15197150 0.77 CYP4F2 (0.43) ALDH1A1L3MBTL1KMT2APOLBTSHR
SCHEMBL16445957 0.77 ALDH1A1 (0.68) ALDH1A1KMT2APOLBLMNATSHR
SCHEMBL256765 0.76 KMT2A (0.49) ALDH1A1L3MBTL1KMT2APOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
EP-2612848-A1 CYCLIC AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2013-07-10 EP disclosed
WO-2012029942-A1 CYCLIC AMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE HDAC10, H1-10, H1-0 ALDH1A1 538/4885L3MBTL1 2569/4885KMT2A 1199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.